海绵体内注射肉毒毒素治疗勃起功能障碍:系统综述与Meta分析
该系统综述检索1990年1月至2021年7月PubMed、Embase和Medline数据库,纳入7项研究(含2项临床前研究),对至少2项研究共同报告的3个结局进行Meta分析。结果显示海绵体内注射A型肉毒毒素(BoNT-A)在勃起硬度评分(EHS)和海绵体动脉收缩期峰值流速(PSV)方面具有统计学显著性获益,但作者指出样本量小、数据收集异质性、患者选择偏倚及所测差异的临床意义等局限性,认为目前应限于临床研究。
核心结论
- 该系统综述与Meta分析显示BoNT-A在EHS和PSV方面具有统计学显著性获益。
- 作者指出该统计学显著性应结合样本量小、数据收集异质性、患者选择偏倚及所测差异的临床意义等局限性来解读。
- 作者认为海绵体内注射BoNT-A目前应限于临床研究,以进一步阐明其临床获益。
研究设计与样本
- 系统综述检索1990年1月至2021年7月31日的文献,检索引擎包括PubMed、Embase和Medline数据库,纳入英文发表的有关肉毒毒素治疗勃起功能障碍的研究。
- 共纳入7项研究,包括2项临床前研究。
- 对至少2项研究共同报告的3个结局进行Meta分析,评估参数包括勃起硬度评分(EHS)、海绵体动脉收缩期峰值流速(PSV)和男性性健康量表(SHIM)评分。
临床怎么用
- 作者认为海绵体内注射BoNT-A目前应限于临床研究,以进一步阐明其临床获益。
局限性
- 样本量小。
- 数据收集存在异质性。
- 存在患者选择偏倚。
- 所测差异的临床意义有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the role of botulinum toxin in treating erectile dysfunction as a novel treatment strategy avoiding morbid and irreversible surgeries. METHODS: A systematic review of literature was conducted from January 1990 through July 31, 2021. Search engines used included PubMed, Embase and Medline databases, to identify studies investigating botulinum toxin in erectile dysfunction, published in English. Seven studies in total were included in our review including two pre-clinical studies. A meta-analysis was performed on three outcomes included commonly in at least two studies. Among the different parameters assessed were, Erection Hardness Score (EHS), Peak Systolic Velocity in cavernosal artery (PSV) and the Sexual Health Inventory for Men (SHIM) score. RESULTS: A clear benefit was noted for intracavernosal injection (ICI) of botulinum toxin (BoNT-A) on PSV with a mean difference (MD) of 10.82 [4.99, 16.65] and a heterogeneity of I2=61%. EHS results favored BoNT-A as well over placebo with a MD of 0.7 [0.47, 0.93] and heterogeneity of I2=94%. As for SHIM score, with a heterogeneity of I2=85%, no statistically significant difference was found (MD 0.58 [-0.03, 1.20]). CONCLUSION: Our review and meta-analysis have shown statistical significance for the benefit of BoNT-A in terms of EHS and PSV. However, this statistical significance should be interpreted in light of the given limitations: small sample size, heterogeneity in data collection, patient selection bias, and clinical significance of the measured differences. ICI of BoNT-A should currently be limited to clinical studies to further elucidate its clinical benefit.
引用
- Abou Zahr R, Bou Kheir G, Mjaess G, et al. Intra-Cavernosal Injection of Botulinum Toxin in the Treatment of Erectile Dysfunction: a Systematic Review and Meta-Analysis. Urology. 2022. PMID: 36115427. doi:10.1016/j.urology.2022.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。